居家赋能与维持老年人独立生活(HomeHealth试验):一项多中心随机对照试验
HomeHealth是一项由志愿部门提供的居家手册化服务,针对轻度衰弱的社区老年人,通过6次会面支持其围绕活动能力、营养、社交和心理健康设定并实现目标。本单盲多中心随机对照试验纳入388名65岁及以上轻度衰弱老年人,1:1随机接受HomeHealth每月一次共6个月或常规治疗。12个月时改良Barthel指数无差异(均差0.250,95%CI -0.932至1.432),6个月时心理困扰和衰弱小幅降低,12个月时幸福感小幅改善。
要点
- HomeHealth在12个月时未维持轻度衰弱老年人的日常生活活动独立性(Barthel指数均差0.250,95%CI -0.932至1.432)。
- 6个月时心理困扰(-1.237,95%CI -2.127至-0.348)和衰弱(-0.124,95%CI -0.232至-0.017)小幅降低。
- 12个月时幸福感小幅改善(1.449,95%CI 0.124至2.775),其他结局无显著差异。
核心结论
- 这项高质量试验表明HomeHealth未能维持轻度衰弱老年人的独立性,对次要结局影响有限。
- 未来研究需要探索促进该人群健康的不同方式。
研究设计与样本
- 单盲多中心随机对照试验,从伦敦、约克郡和赫特福德郡的27家全科诊所、社区团体和庇护性住房招募65岁及以上轻度衰弱的社区居住老年人。
- 参与者按1:1随机分配接受每月一次共6个月的HomeHealth或常规治疗(常规全科和门诊照护,无特定衰弱服务)。
- 主要结局为日常生活活动独立性,由盲法结局评估者使用改良Barthel指数测量,采用线性混合模型分析,纳入6个月和12个月数据并控制基线Barthel评分和站点。
- 试验于2021年1月18日至2023年7月4日进行,共招募388名参与者(平均年龄81.4岁;64%女性[n=250],94%白人英国/欧洲裔[n=364],2.5%亚裔[n=10],1.5%黑人[n=6],2.0%其他[n=8])。
- 6个月随访保留率89%(345/388),12个月随访保留率86%(334/388),病历数据保留率89%(347/388);干预组195人中182人(93%)完成干预,平均参加5.6次会面。
主要发现
- 12个月时HomeHealth对Barthel指数评分无影响(均差0.250,95%CI -0.932至1.432)。
- 6个月时心理困扰小幅降低(-1.237,95%CI -2.127至-0.348),衰弱小幅降低(-0.124,95%CI -0.232至-0.017)。
- 12个月时接受HomeHealth者幸福感出现小幅积极效应(1.449,95%CI 0.124至2.775)。
- 截至目前分析的其他结局显示无显著差异。
- 健康经济结局(包括生活质量、能力、卫生服务使用和照护需求或负担)待报告。
临床怎么用
- 原文未据此给出推荐。
局限性
- 健康经济结局(包括生活质量、能力、卫生服务使用和照护需求或负担)待报告。
- 未来研究需要探索促进该人群健康的不同方式。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: NHS frailty services commonly target more severely frail older people, despite evidence suggesting frailty can be prevented or reversed when addressed at an earlier stage. HomeHealth is a new home-based, manualised voluntary sector service supporting older people with mild frailty to maintain their independence through behaviour change. Over six appointments, a trained HomeHealth worker discusses what matters to the older person and supports them to set and achieve goals around mobility, nutrition, socialising and/or psychological wellbeing. The service showed promising effects in a feasibility trial. We aimed to test the clinical and cost-effectiveness of HomeHealth for maintaining independence in older people with mild frailty compared with treatment as usual. METHODS: In this single-blind multicentre randomised controlled trial, we recruited community-dwelling older people aged 65 years or older with mild frailty from 27 general practices, community groups and sheltered housing in London, Yorkshire, and Hertfordshire. Participants were randomly assigned (1:1) to receive either HomeHealth monthly for 6 months or treatment as usual (usual GP and outpatient care, no specific frailty services). Our primary outcome was independence in activities of daily living, measured by blinded outcome assessors using the modified Barthel Index, and analysed using linear mixed models, including 6-month and 12-month data and controlling for baseline Barthel score and site. The study was approved by the Social Care Research Ethics Committee, and all participants provided written or orally recorded informed consent. This study is registered with the ISRCTN registry, ISRCTN54268283. FINDINGS: This trial took place between Jan 18, 2021, and July 4, 2023. We recruited 388 participants (mean age 81·4 years; 64% female [n=250], 94% White British/European [n=364], 2·5% Asian [n=10], 1·5% Black [n=6], 2·0% other [n=8]). We achieved high retention for 6-month follow-up (89%, 345/388), 12-month follow-up (86%, 334/388), and medical notes data (89%, 347/388). 182 (93%) of 195 participants in the intervention group completed the intervention, attending a mean of 5·6 appointments. HomeHealth had no effect on Barthel Index scores at 12 months (mean difference 0·250, 95% CI -0·932 to 1·432). At 6 months, there was a small reduction in psychological distress (-1·237, -2·127 to -0·348) and frailty (-0·124, -0·232 to -0·017), and at 12 months, we found small positive effects on wellbeing (1·449, 0·124 to 2·775) in those receiving HomeHealth. Other outcomes in analysis to date showed no significant difference. Health economic outcomes (including quality of life, capability, health services use and care needs or burden) are pending. INTERPRETATION: This high-quality trial showed that HomeHealth did not maintain independence in older people with mild frailty, and had limited effects upon secondary outcomes. Future studies need to explore different ways to promote health in this population. FUNDING: National Institute for Health and Care Research Health Technology Assessment (NIHR HTA).
引用
- Frost R, Avgerinou C, Kalwarowsky S, et al. Enabling health and maintaining independence for older people at home (HomeHealth trial): a multicentre randomised controlled trial. Lancet. 2023. PMID: 37997084. doi:10.1016/S0140-6736(23)02071-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。